The total number of kidney grafts performed in Scandiatransplant is 3,915 of which 514 are from 1978. The waiting list seems to be stable at approx. 600 patients. The correlation of HLA-A, B matching and graft survival is highly significant. 3rd and 4th grafts have a much lower survival than 1st and 2nd. Overall results have decreased somewhat during the years.
Instead of disappearing, Alaska Eskimo and Indian villages continue to exist, but in a complex and altered form. Using the age/sex curve we find increased numbers of dependent persons in the Native population. Young adults are being attracted to the larger villages, and the smallest villages are most rapidly losing young adults, though they retain large numbers of children.
It is suggested that part of the acculturative difficulty facing Alaska Eskimos and Indians is a function of a dramatically altered population structure in which proper childhood socialization is nearly impossible.
From: Fortuine, Robert et al. 1993. The Health of the Inuit of North America: A Bibliography from the Earliest Times through 1990. University of Alaska Anchorage. Citation number 1444.
The Alberta Congenital Anomalies Surveillance System was started in 1966 in response to the thalidomide tragedy earlier in the decade. It was one of four provincial surveillance systems on which the federal government relied for baseline statistics of congenital anomalies. The government now collects data from six provinces and one territory. The Alberta Congenital Anomaly Surveillance System originally depended on three types of notification to the Division of Vital Statistics, Department of Health, Government of Alberta: birth notice and certificates of death and stillbirth; increased sources of ascertainment have greatly improved data quality. We present the data for 1980-86 and compare the prevalence rates of selected anomalies with the rates from three other surveillance systems. Surveillance systems do not guarantee that a new teratogen will be detected, but they are extremely valuable for testing hypotheses regarding causation. At the very least they provide baseline data with which to compare any deviation or trend. For many, if not most, congenital anomalies total prevention is not possible; however, surveillance systems can be used to measure progress in prevention.
Cites: Int J Epidemiol. 1977 Mar;6(1):35-41892967
Cites: Teratology. 1977 Dec;16(3):277-83594911
Cites: Am J Cardiol. 1978 Oct;42(4):641-7696646
Cites: Teratology. 1968 Aug;1(3):263-805759547
Cites: Int J Epidemiol. 1981 Sep;10(3):247-527287285
Cites: Teratology. 1981 Dec;24(3):277-837330776
Cites: Lancet. 1982 Oct 23;2(8304):9376126782
Cites: Med J Aust. 1983 Aug 20;2(4):189-916877168
Cites: J Epidemiol Community Health. 1984 Dec;38(4):296-3056512482
Cites: Am J Med Genet. 1985 Nov;22(3):545-523840650
BACKGROUND AND OBJECTIVE: Physicians may find it confusing to decide whether to report diagnoses in part I or part II of the death certificate. The aim of this study was to contrast differences in diabetes mortality through a comparison of physicians' habits in reporting diabetes in part I of death certification among Taiwan, Australia, and Sweden. METHODS: A cross-sectional, intercountry comparison study. We calculated the proportion of deaths with mention of diabetes in which diabetes was reported in part I of the death certificate and the proportion of deaths with mention of diabetes in which diabetes was selected as underlying cause of death. RESULTS: We found that half of the differences in reported diabetes mortality among Taiwan, Australia, and Sweden were due to differences in reporting deaths with mention of diabetes anywhere on the certificate, and half due to differences in proportion of deaths with mention of diabetes in which diabetes was reported in part I of the death certificate. CONCLUSION: Differences in the reporting of diabetes in part I of the death certificate among physicians in Taiwan, Australia, and Sweden was one of the factors that affected differing reported diabetes mortality in Taiwan, Australia, and Sweden.
The authors hypothesize that recent single or multiinstitution-based reports of improved survival of congenital diaphragmatic hernia (CDH) patients are biased by patient selection, practice, and referral patterns. Here the authors report a population-based analysis of the clinical outcomes of CDH in the province of Ontario for 1996.
A retrospective analysis of cross-sectional data from the Bureau of Vital Statistics of Ontario and all 5 pediatric surgical institutions in Ontario for 1996 was performed.
Twenty-four CDH-associated deaths were registered in Canada in 1996. Fourteen of 24 occurred in Ontario (58.3%). Of 30 institutionally identified CDH in Ontario, 8 patients died (26.7%). CDH-associated infant mortality rate was 6.6 of 100,000 live births in Canada compared with 10 of 100,000 live births for Ontario (Relative risk, 1.4; confidence interval, 0.5, 3.7; P >.01). Neonatal death (